ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 20 filers reported holding ALBIREO PHARMA INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,000 | -50.0% | 49 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $2,000 | 0.0% | 49 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $2,000 | +100.0% | 49 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 49 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $2,000 | 0.0% | 49 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $2,000 | 0.0% | 49 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $2,000 | +100.0% | 49 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $1,000 | 0.0% | 49 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $1,000 | 0.0% | 49 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,000 | 0.0% | 49 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $1,000 | 0.0% | 49 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $1,000 | – | 49 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 330,407 | $5,409,000 | 2.53% |
| Perceptive Advisors | 1,960,139 | $31,931,000 | 0.83% |
| Birchview Capital, LP | 48,000 | $786,000 | 0.70% |
| Chicago Capital, LLC | 492,878 | $8,068,000 | 0.65% |
| Artal Group S.A. | 588,125 | $9,628,000 | 0.41% |
| PA Capital LLC | 23,198 | $380,000 | 0.34% |
| Eversept Partners, LP | 78,029 | $1,277,335 | 0.32% |
| HEARTLAND ADVISORS INC | 150,000 | $2,456,000 | 0.26% |
| ArrowMark Colorado Holdings LLC | 972,372 | $15,918,000 | 0.21% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 25,268 | $414,000 | 0.14% |